Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
32 /100
MEDIUM RISK
Score updated Oct 13, 2026

TRDA — Entrada Therapeutics, Inc. Dilution Risk Tracker

Track TRDA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TRDA — Get alerts when the score changes →

As of October 13, 2026, Entrada Therapeutics, Inc. (TRDA) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. Entrada Therapeutics, Inc. has a market capitalization of $214.15M, 38.94M shares outstanding, 119 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway—
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TRDA.
🔔 Track TRDA — Get forecast alerts →

Market Data

Market Cap$214.15M
Shares Outstanding38.94M
Float19.47M
Cash$261.54M
Debt$49.75M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore32/100DilutionWatch score record
Shares Outstanding38.94MVerified float table or market cache
Public Float19.47MVerified float table or market cache
Market Cap$214.15MMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 13.8% shares (2026Q1 vs prior)
119 institutional holders · 28.17M shares
#1 BAKER BROS. ADVISORS LP 5.07M shares
#2 5AM Venture Management, LLC 4.06M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 2.51M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.99M
Days to Cover9.9
% of Float15.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-03-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TRDA Dilution Snapshot

Entrada Therapeutics, Inc. (TRDA) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TRDA's DilutionScore is currently 32/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 31/100 (Medium risk).

Period Score Risk Level Duration
Jul 17 – Oct 13, 202632/100MEDIUM88 days
Jul 16, 202631/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TRDA shares outstanding have increased 1.6% from 38.22M (Mar 2026) to 38.82M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 202638.82M19.47M▼ 8.99%
May 18, 202638.82M21.39M▼ 0.92%
May 16, 202638.82M21.59M▼ 0.91%
May 12, 202638.82M21.79M▼ 7.18%
May 08, 202638.82M23.48M▲ 7.06%
May 03, 202638.82M21.93M▲ 0.96%
Apr 27, 202638.28M21.72M▲ 0.63%
Apr 15, 202638.28M21.58M▲ 0.01%
Mar 17, 202638.28M21.58M▲ 0.17%
Mar 13, 202638.28M21.54M▼ 0.77%
Mar 09, 202638.28M21.71M▼ 0.51%
Mar 05, 202638.22M21.82M▲ 0.25%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TRDA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TRDA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TRDA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TRDA
TRDA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.